Attached files

file filename
EX-31.2 - CHINA PHARMA HOLDINGS, INC.cphi10kaex312123114.htm
EX-32.1 - CHINA PHARMA HOLDINGS, INC.cphi10kaex321123114.htm
EX-31.1 - CHINA PHARMA HOLDINGS, INC.cphi10kaex311123114.htm
10-K/A - CHINA PHARMA - CHINA PHARMA HOLDINGS, INC.cphi10ka123114.htm
 
 
 

 

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 

We consent to the incorporation by reference in Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 30, 2015 (except for Note 1, as to which the date is December 24, 2015) relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries as of and for the year ended December 31, 2014 appearing in this Amendment No. 1 to the Annual Report on Form 10-K/A of China Pharma Holdings, Inc. for the year ended December 31, 2014.


/s/ ARSHAK DAVTYAN, INC.

ARSHAK DAVTYAN, INC.
Salt Lake City, Utah
December 24, 2015